MetLife Gets Positive Feedback from Analysts

Group 1 - MetLife, Inc. is recognized as one of the 9 best life insurance stocks to buy currently [1] - Analyst opinions on MetLife are modestly positive, with over 60% assigning a Buy or equivalent rating, and a consensus 1-year median price target of $93, indicating an upside of over 18%-19% [2] - MetLife announced Q4 2025 preferred stock dividends, including a quarterly dividend of $0.33 per share on its Series A preferred stock [3][4] Group 2 - MetLife completed the transfer of $10 billion in variable annuity risk to Talcott Resolution Life Insurance Company, which will result in a foregone annual adjusted earnings of approximately $100 million, offset by $45 million in annual hedge cost savings [5] - This transaction expedites the run-off of conventional U.S. Retail segment businesses and reduces risk exposure within MetLife Holdings [5] - MetLife Investment Management has signed new agreements with Talcott to manage around $6 billion in assets [5]